JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
2.910
-0.040 (-1.36%)
Jul 4, 2025, 4:08 PM HKT
HKG:2126 Market Cap
HKG:2126 has a market cap or net worth of 1.18 billion as of July 3, 2025. Its market cap has increased by 25.81% in one year.
Market Cap
1.18B
Enterprise Value
817.66M
Revenue
168.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.91
Market Cap Chart
Since November 3, 2020, HKG:2126's market cap has decreased from 8.28B to 1.18B, a decrease of -85.75%. That is a compound annual growth rate of -34.12%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 4, 2025 | 1.18B | 127.72% |
Dec 31, 2024 | 518.01M | -42.89% |
Dec 29, 2023 | 907.01M | -47.90% |
Dec 30, 2022 | 1.74B | -67.36% |
Dec 31, 2021 | 5.33B | -47.83% |
Dec 31, 2020 | 10.22B | 23.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines | 228.27B |
Hansoh Pharmaceutical Group Company | 185.21B |
Innovent Biologics | 142.37B |
JD Health International | 132.80B |
WuXi Biologics | 106.60B |
Akeso | 104.21B |
Sino Biopharmaceutical | 100.15B |
CSPC Pharmaceutical Group | 93.15B |